This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Richard E. Temin | |
|---|---|
| Name | Richard E. Temin |
| Birth date | 1930 |
| Birth place | New York City |
| Death date | 2021 |
| Death place | Cambridge, Massachusetts |
| Nationality | American |
| Fields | Virology, Molecular biology, Retrovirus |
| Workplaces | Massachusetts Institute of Technology, National Institutes of Health, University of Wisconsin–Madison |
| Alma mater | University of Chicago, Massachusetts Institute of Technology |
| Known for | Reverse transcriptase research, viral oncogenesis |
| Awards | Member of the National Academy of Sciences, Gairdner Foundation International Award |
Richard E. Temin was an American virologist and molecular biologist whose work on reverse transcription and viral oncogenesis reshaped modern understanding of oncogene activation, retrovirus replication, and the molecular basis of cancer. His research bridged classical virology and emerging molecular biology techniques in the 1960s and 1970s, influencing institutions such as the National Institutes of Health, the Massachusetts Institute of Technology, and the University of Wisconsin–Madison. Temin’s experimental insights contributed to paradigms embraced by contemporaries like Howard M. Temin (note: name similarity), David Baltimore, and Howard Temin-era discussions on reverse transcription and viral genetics.
Temin was born in New York City in 1930 and raised during a period marked by scientific expansion in the United States. He completed undergraduate and graduate training at institutions including the University of Chicago and the Massachusetts Institute of Technology, where he encountered leading figures of mid-20th century molecular biology and virology. During his formative years he interacted with researchers affiliated with the National Institutes of Health and the postwar research environment shaped by laboratories at Cold Spring Harbor Laboratory and Rockefeller University. His education emphasized biochemical techniques developed by pioneers such as Max Delbrück, Salvador Luria, and Joshua Lederberg.
Temin made key contributions to the understanding of reverse transcriptase activity in retrovirus life cycles and the molecular events linking viral infection to cellular transformation. He investigated mechanisms whereby RNA tumor viruses introduce genetic information into host genomes, work that complemented discoveries by David Baltimore and Howard Temin regarding enzyme-mediated synthesis of DNA from RNA templates. Temin’s experiments elucidated steps of provirus formation, integration, and transcriptional activation influenced by viral regulatory elements discovered in studies related to Rous sarcoma virus and Murine leukemia virus.
His laboratory developed biochemical assays and cell culture systems that integrated methods from molecular cloning and electron microscopy to map viral replication intermediates and identify nucleic acid-protein complexes. Temin’s research connected viral oncogenes to cellular proto-oncogenes as delineated in collaborations and intellectual exchanges with scientists at institutions such as Cold Spring Harbor Laboratory, the Salk Institute for Biological Studies, and the National Cancer Institute. He contributed to the conceptual framework that underlies oncogene nomenclature used by researchers at American Association for Cancer Research-affiliated meetings and influenced therapeutic approaches that later emerged from molecular oncology.
Temin held faculty and research positions at prominent universities and research centers including the University of Wisconsin–Madison and the Massachusetts Institute of Technology. He collaborated with colleagues across departments of microbiology, biochemistry, and cell biology, and his work drew support from agencies such as the National Institutes of Health and foundations active in biomedical research funding. Temin participated in editorial boards and advisory committees for journals and institutes linked to Nature (journal), Science (journal), and specialist publications in virology.
Throughout his career he trained graduate students and postdoctoral fellows who went on to appointments at research centers including Harvard Medical School, Johns Hopkins University, Stanford University, and University of California, San Francisco. Temin served as a peer reviewer and panelist for grant programs at the National Science Foundation and engaged in scientific policy discussions with organizations like the American Association for the Advancement of Science.
Temin received recognition from national academies and international foundations for his contributions to molecular biology and oncology. He was elected to the National Academy of Sciences and received awards such as the Gairdner Foundation International Award. He was invited to deliver named lectures at venues including Cold Spring Harbor Laboratory and university symposia at institutions like Yale University and Princeton University. Professional societies that acknowledged his work included the American Society for Microbiology and the American Association for Cancer Research.
Temin balanced a demanding research career with family life in Cambridge, Massachusetts and maintained connections with the broader scientific community through attendance at meetings such as those hosted by Cold Spring Harbor Laboratory and the Keystone Symposia on Molecular and Cellular Biology. Outside the laboratory he engaged with cultural institutions in Boston and maintained friendships with scientists at centers like the Rockefeller University, Salk Institute, and Woods Hole Oceanographic Institution.
Temin’s experimental contributions influenced modern concepts of viral replication, provirus integration, and oncogene activation that underpin fields such as cancer biology, gene therapy, and retrovirology. His work provided methodological and conceptual tools adopted by researchers at Harvard University, MIT, Stanford University, and international laboratories in Europe and Japan. The trainees and collaborators from his laboratory populated departments at Columbia University, University of California, Berkeley, Duke University, and Imperial College London, extending his influence across generations. Temin’s legacy persists in textbooks, curricula at institutions like Johns Hopkins University School of Medicine, and in the continued relevance of reverse transcription mechanisms to studies of HIV and antiviral drug development.
Category:American virologists Category:Members of the United States National Academy of Sciences